Company
United StatesPublic company, NYSE: AZNAstraZeneca, PLC (NYSE: AZN), San Diego, CA – FDA Inspections
Inspection records and compliance data for AstraZeneca, PLC in San Diego, California. 7 FDA inspections on record, last inspected March 20, 2015. Publicly traded as NYSE: AZN.
Company Profile
This profile covers AstraZeneca, PLC based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 1
- NAI
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected January 20, 2009. Last inspected March 20, 2015.
Most cited issue areas
- No written record of investigation1 inspection
- Procedures not in writing, fully followed1 inspection
- Scientifically sound laboratory controls1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 20, 2015 | VAI | Human Drugs · Drug Quality Assurance | 922364 |
| March 27, 2013 | NAI | Human Drugs · Drug Quality Assurance | 824640 |
| December 21, 2011 | NAI | Human Drugs · Drug Quality Assurance | 759884 |
| August 27, 2010 | NAI | Human Drugs · Bioresearch Monitoring | 680556 |
| September 25, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 616272 |
| March 26, 2009 | NAI | Human Drugs · Drug Quality Assurance | 571860 |
| January 20, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 557061 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AstraZeneca, PLC
Stock ticker
AZN
Exchange
NYSE
Share price
$187.08
Market cap
$290.1B
Price as of
November 6, 2026
FEI Number
1000519848
Address
9625 Towne Centre Dr, San Diego, California 92121, United States
Country
United States
ID: 6293ea11-7657-47b7-8ae6-b97f9afcae84